Clinical outcome of pazopanib in Japanese patients with soft tissue sarcoma; Multicenter study
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2016
Price : $35 *
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 13 Jun 2016 Status changed from active, no longer recruiting to completed.
- 12 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 16 Dec 2013 New trial record